Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly

Psychosomatic Medicine

Volumn 69, Issue 5, 2007, Pages 483-489

  Buchman, Aron S ^a,b   Boyle, Patricia A ^a,b   Wilson, Robert S ^a,b   Tang, Yuxiao ^c   Bennett, David A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Alzheimer's disease; Cognitive decline; Dementia; Frailty

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED STUDY; COURSE EVALUATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRAIL ELDERLY; GERIATRIC PATIENT; HAZARD ASSESSMENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SAMPLE SIZE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; FEMALE; FRAIL ELDERLY; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; RISK FACTORS;

EID: 34250828438     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/psy.0b013e318068de1d     Document Type: Article

References (54)

1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-56.
2. Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB Jr, Walston JD. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc 2004;52:625-34.
3. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004;59:255-63.
4. Mitnitski AB, Song X, Rockwood K. The estimation of relative fitness and frailty in community-dwelling older adults using self-report data. J Gerontol A Biol Sci Med Sci 2004;59:M627-32.
5. Cronin-Stubbs D, Beckett LA, Scherr PA, Field TS, Chown MJ, Pilgrim DM, Bennett DA, Evans DA. Weight loss in people with Alzheimer's disease: a prospective population based analysis. BMJ 1997;314:178-9.
6. Scarmeas N, Albert M, Brandt J, Blacker D, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Wegesin D, Marder K, Bell K, Honig L, Stern Y. Motor signs predict poor outcomes in Alzheimer disease. Neurology 2005;64:1696-703.
7. Mitchell SL, Rockwood K. The association between parkinsonism, Alzheimer's disease, and mortality: a comprehensive approach. J Am Geriatr Soc 2000;48:422-5.
8. Wang L, Larson EB, Bowen JD, van Belle G. Performance-based physical function and future dementia in older people. Arch Intern Med 2006;166:1115-20.
9. Bennett DA, Schneider JA, Buchman AS, Mendes de Leon C, Bienias JL, Wilson RS. The Rush memory and aging project: study design and baseline characteristics of the study cohort. Neuroepidemiology 2005;25:163-75.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
11. Wechsler D. Wechsler Memory Scale - Revised Manual. San Antonio, Texas: Psychological Corporation; 1987.
12. Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-78.
13. Wilson RS, Beckett LA, Barnes LL, Schneider JA, Bach J, Evans DA, Bennett DA. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-93.
14. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-65.
15. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger; 1983.
16. Cooper JA, Sagar HJ. Incidental and intentional recall in Parkinson's disease: an account based on diminished attentional resources. J Clin Exp Neuropsychol 1993;15:713-31.
17. Smith A. Symbol Digit Modalities Test Manual-Revised. Los Angeles: Western Psychological Services; 1992.
18. Ekstrom R, French J, Harman H, Kermen D. Manual for Kit of Factor-Referenced Cognitive Tests. Princeton, NJ: Educational Testing Service; 1976.
19. Trenerry M, Crosson B, DeBoe J, Leber W. The Stroop Neuropsychological Screening Test. Odessa, FL: Psychological Assessment Resources; 1989.
20. Benton A, Sivan A, Hamsher K, Varney N, Spreen O. Contributions to Neuropsychological Assessment. 2nd ed. New York: Oxford University Press; 1994.
21. Raven J, Court J, Raven J. Manual for Raven's Progressive Matrices and Vocabulary: Standard Progressive Matrices. Oxford: Oxford Psychologists Press; 1992.
22. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. Philadelphia: Lea & Febiger; 1972.
23. Wilson RS, Barnes LL, Krueger KR, Hoganson G, Bienias JL, Bennett DA. Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc 2005;11:400-7.
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
25. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
26. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
27. Robins LN, Helzer JE, Ratcliff KS, Seyfried W. Validity of the diagnostic interview schedule, version II: DSM-III diagnoses. Psychol Med 1982;12:855-70.
28. Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF, Fox JH, Cochran EJ, Arends D, Treinkman AD, Wilson RS. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 2006;27:169-76.
29. Wilson RS, Buchman AS, Arnold SE, Shah RC, Tang Y, Bennett DA. Harm avoidance and disability in old age. Exp Aging Res 2006;32:243-61.
30. Boyle PA, Wilson RS, Aggarwal NT, Arvanitakis Z, Kelly J, Bienias JL, Bennett DA. Parkinsonian signs in subjects with mild cognitive impairment. Neurology 2005;65:1901-6.
31. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology 2005;65:892-7.
32. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
33. Collett D. Modeling Survival Data in Medical Research 2nd ed. Boca Raton, Florida: Chapman & Hall; 2003.
34. SAS. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute Inc; 2000.
35. Waite LM, Grayson DA, Piguet O, Creasey H, Bennett HP, Broe GA. Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney older persons study. J Neurol Sci 2005;229-230:89-93.
36. Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. Arch Neurol 2003;60:539-44.
37. Rockwood K, Howlett SE, MacKnight C, Beattie BL, Bergman H, Hebert R, Hogan DB, Wolfson C, McDowell I. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci 2004;59:1310-7.
38. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475-83.
39. Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, Walston JD, Fried LP. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001;56:M158-66.
40. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004;61:661-6.
41. Puts MT, Visser M, Twisk JW, Deeg DJ, Lips P. Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf) 2005;63:403-11.
42. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002;59:371-8.
43. Ehl C, Kolsch H, Ptok U, Jessen F, Schmitz S, Frahnert C, Schlosser R, Rao ML, Maier W, Heun R. Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease. Int J Mol Med 2003;11:235-8.
44. Ma SL, Tang NL, Lam LC, Chiu HF. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiol Aging 2005;26:1005-10.
45. Liu Y, Stern Y, Chun MR, Jacobs DM, Yau P, Goldman JE. Pathological correlates of extrapyramidal signs in Alzheimer's disease. Ann Neurol 1997;41:368-74.
46. Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DW. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology 2005;64:1397-403.
47. Gearing M, Levey AI, Mirra SS. Diffuse plaques in the striatum in Alzheimer disease (AD): relationship to the striatal mosaic and selected neuropeptide markers. J Neuropathol Exp Neurol 1997;56:1363-70.
48. Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS. Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis Assoc Disord 1999;13:226-31.
49. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005;64:834-41.
50. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006;66:1837-44.
51. Schneider JA, Li JL, Li Y, Wilson RS, Kordower JH, Bennett DA. Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol 2006;59:166-73.
52. Buchman AS, Schneider JA, Wilson RS, Bienias JL, Bennett DA. Body mass index in older persons is associated with Alzheimer disease pathology. Neurology 2006;67:1949-54.
53. Wilson RS, Krueger KR, Arnold SE, Schneider JA, Kelly JF, Barnes LL, Tang Y, Bennett DA. Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry 2007;64:234-40.
54. Wilson RS, Schneider JA, Bienias JL, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology 2003;61:1102-7.